Cite

HARVARD Citation

    Smola, A. et al. (2021). Omalizumab prevents anaphylactoid reactions to mRNA COVID‐19 vaccine. Journal of the European Academy of Dermatology and Venereology. pp. e743-e745. [Online]. 
  
Back to record